Profile
NEPT TAK ZTS HLN TEVA VTRS
Company Name Neptune Wellness Solutions Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $857.05K $56.52B $56.15B $49.48B $39.78B $14.94B
Employees 0.05K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Lisa H. Gainsborg CPA Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
NEPT TAK ZTS HLN TEVA VTRS
Quant Rating Score 3 3 3 4 3 2
Quant Rating Neutral Neutral Neutral Buy Neutral Sell
Trading
NEPT TAK ZTS HLN TEVA VTRS
Last Close $0.2 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $0.2 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $0.2 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High 0 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 0 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
NEPT TAK ZTS HLN TEVA VTRS
1 Month Return 0 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return 0 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 0 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 0 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 0 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 0 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NEPT TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.6 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -30.68 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Profitability
NEPT TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM -4.7 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -195.48 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -334.26 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM 1017.7 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 68.08 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 86.34 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -195.47 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -112.87 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 7.01 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 2.68 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 4.24 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 1573.14 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 170.12 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -3869.65 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -3995.78 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 27239.19 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -54.29 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.26 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -112.87 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM - 9.34 25.07 38.08 25.95 9.34
Price To Operating Cash Flows Ratio TTM - 7.75 19.35 35.1 19.5 7.62
Price Cash Flow Ratio TTM - 7.75 19.35 35.1 19.5 7.62
Income Statement (TTM)
NEPT TAK ZTS HLN TEVA VTRS
Revenue $0.05B $4581.55B $9.26B $11.23B $17.26B $14.74B
Gross Profit $-0.02B $3001.33B $6.4B $6.95B $8.94B $5.62B
Gross Profit Ratio -41.51% 65.51% 69.1% 61.85% 51.79% 38.15%
EBITDA $-0.06B $1210.51B $3.87B $2.51B $3.14B $2.82B
Net Income $-0.08B $107.93B $2.49B $1.44B $1.41B $-0.63B
EPS Diluted -276.7 33.62 5.47 0.32 1.2 -0.53
Balance Sheet (MRQ)
NEPT TAK ZTS HLN TEVA VTRS
Long Term Debt $0.02B $3966.33B $5.39B $8.62B $15.56B $14.22B
Total Liabilities $0.06B $7312.37B $9.47B $18.09B $32.83B $22.87B
Total Equity $-0.03B $6935.98B $4.77B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0.03B $0.14B $0B $1.7B
Total Debt $0.03B $4515.27B $6.74B $10.1B $17.38B $14.31B
Total Assets $0.03B $14248.34B $14.24B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
NEPT TAK ZTS HLN TEVA VTRS
Net Income $107.93B $2.5B $1.44B $1.42B $-0.63B
Inventory $-34.97B $-0.04B $0.22B $0.15B $-0.72B
Dividends Paid $-302.5B $-0.79B $-0.57B $0B $-0.57B
Operating Cash Flow $1057.18B $2.95B $2.3B $1.65B $2.3B
Capital Expenditure $-200.8B $-0.66B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.465
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.9529
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.04
ALVOW Alvotech 0.4511
AMPH Amphastar Pharmaceuticals, Inc. 28.565
AMRX Amneal Pharmaceuticals, Inc. 14.385
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 80.7318
APUS Apimeds Pharmaceuticals US, Inc 1.6
AQST Aquestive Therapeutics, Inc. 3.8699
ASRT Assertio Holdings, Inc. 12.25
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.66
ETFs With Exposure to NEPT
Ticker ETF Name Weight Percentage Price
TOKE Cambria Cannabis ETF 1.63 5.8285
CNBS Amplify Growth Opportunities ETF 0 25
Unlock